Prescription drug · ANDA
Liothyronine Sodium NDC 75907-001
Liothyronine sodium 25 ug/1 · Tablet · Oral · Dr. Reddy's Labratories Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 75907-001-01 | 75907000101 | 100 TABLET in 1 BOTTLE, PLASTIC (75907-001-01)Marketed from Mar 15, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Liothyronine Sodium
- Generic name (nonproprietary)
- liothyronine sodium
- Active ingredients
- Liothyronine sodium — 25 ug/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Dr. Reddy's Labratories Inc.NDC labeler code 75907
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090097
- Marketing start
- Listing expires
- Other FDA classes
- Triiodothyronine (Chemical structure)
- Identifiers
- Product ID 75907-001_284a71c7-5913-ff21-9733-f0cf9fc379c2SPL ID 284a71c7-5913-ff21-9733-f0cf9fc379c2SPL set ID 0b0f2db9-642d-d84f-b102-b43de34bbe75RxCUI 903456, 903697, 903703UNII GCA9VV7D2N
- Pharmacologic class
- l-Triiodothyronine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N475907000101followed by a unit qualifier and the quantityPackage 75907-0001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Liothyronine sodium tablets are an L-triiodothyronine (T3) indicated for: Hypothyroidism: As replacement in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism ( 1.1 ) Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer ( 1.2 ) Thyroid Suppression Test: As a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy ( 1.3 ) Limitations of Use : - Not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients. ( …
Excerpt only. Read the full label for complete information.
About NDC 75907-001
- What is NDC 75907-001?
- 75907-001 is the product NDC for Liothyronine Sodium, Liothyronine sodium 25 ug/1 tablet, listed with the FDA by Dr. Reddy's Labratories Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Liothyronine Sodium.
- What is the active ingredient?
- Liothyronine sodium.
- Who is the labeler?
- Dr. Reddy's Labratories Inc., NDC labeler code 75907. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Liothyronine Sodium?
- 44 other product NDCs are listed under this name. See all Liothyronine Sodium NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Liothyronine Sodium products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Liothyronine Sodium | Liothyronine sodium 50 ug/1 | TabletOral | Dr. Reddy's Labratories Inc. | 75907-004 | 75907-0004-01 |
| Liothyronine Sodium | Liothyronine sodium 5 ug/1 | TabletOral | Dr. Reddy's Labratories Inc. | 75907-039 | 75907-0039-01 |
| Liothyronine sodium | Liothyronine sodium 5 ug/1 | TabletOral | Biocon Pharma Inc. | 70377-114 | 70377-0114-1170377-0114-1270377-0114-13 |
| Liothyronine sodium | Liothyronine sodium 25 ug/1 | TabletOral | Biocon Pharma Inc. | 70377-115 | 70377-0115-1170377-0115-1270377-0115-13 |
| Liothyronine sodium | Liothyronine sodium 50 ug/1 | TabletOral | Biocon Pharma Inc. | 70377-116 | 70377-0116-1170377-0116-1270377-0116-13 |
| Liothyronine sodium | Liothyronine sodium 5 ug/1 | TabletOral | Northstar Rx LLC | 16714-166 | 16714-0166-01 |
| Liothyronine sodium | Liothyronine sodium 25 ug/1 | TabletOral | Northstar Rx LLC | 16714-167 | 16714-0167-01 |
| Liothyronine sodium | Liothyronine sodium 50 ug/1 | TabletOral | Northstar Rx LLC | 16714-168 | 16714-0168-01 |
| Liothyronine Sodium | Liothyronine sodium 25 ug/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-2178 | 00093-2178-01 |
| Liothyronine Sodium | Liothyronine sodium 5 ug/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-2179 | 00093-2179-01 |
Other NDCs under ANDA 090097
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Liothyronine Sodium | Liothyronine sodium 50 ug/1 | TabletOral | Dr. Reddy's Labratories Inc. | 75907-004 |
| Liothyronine Sodium | Liothyronine sodium 5 ug/1 | TabletOral | Dr. Reddy's Labratories Inc. | 75907-039 |
| Liothyronine Sodium | Liothyronine sodium 5 ug/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-384 |